Abstract We conducted a meta-analysis to assess the association between tumor necrosis factor-alpha (TNFalpha) gene TNFA-308 (G [ A) and TNFA-857 (C [ T) polymorphisms and gastric cancer (GC) susceptibility. We also performed subgroup analyses based on ethnicity (Caucasian, east Asian, and other populations) and tumor location [noncardia gastric cancer (NCGC)]. There were 3,335 GC patients and 5,286 controls for TNFA-308, and 1,118 GC patients and 1,591 controls for TNFA-857 in our analysis. Overall, allele contrast (A vs. G) of TNFA-308 polymorphism produced significant results in worldwide populations [P heterogeneity = 0.05, random-effects (RE) odds ratio (OR) 1.19; 95% confidence interval (CI) 1.03-1.37, P = 0.02] and Caucasian populations (P heterogeneity = 0.15, fixed-effects (FE), OR 1.27; 95% CI 1.11-1.45, P = 0.0005). Similar results were also obtained in recessive models and homozygote contrasts. No significant association was observed in NCGC and east Asian subgroup analysis. T variant of TNFA-857 produced significant results only in allele contrast (P heterogeneity = 0.38, FE OR 1.17; 95% CI 1.01-1.35, P = 0.04). In conclusion, TNFA-308 locus of TNF-alpha would be a risk factor for GC, especially in Caucasian populations. Besides, TNFA-857 locus may be related to GC risk, which demonstrated changeability of results in different contrasts.
Introduction
Gastric cancer (GC) is now one of the most common cancers and a universal cause of death from cancer in the world. Studies suggest that GC is related to many factors, including Helicobacter pylori infection, gastroduodenal lesion, and genetic polymorphism, among which variants of pro-and anti-inflammatory cytokines such as interleukin (IL) and tumor necrosis factors (TNF) are most extensively investigated.
TNF-alpha is a proinflammatory cytokine initially identified as a serum factor inducing necrosis of transplanted tumors in mice (Carswell et al. 1975) . It has been proven that TNF-alpha plays an essential role in host defense against infectious diseases, whereas its uncontrolled, excessive production may cause organ dysfunction (Strieter et al. 1993) . There is also evidence suggesting that blood level of TNF-alpha is increased in solid tumors (Ardizzoia et al. 1992 ). Therefore, it seems likely that the expression level of TNF-alpha may be involved in cancer pathogenesis and progression. Functional reports of TNFalpha also suggest that has an effect on GC risk, especially H. pylori-related GC. TNF-alpha is a potent gastric acid inhibitor (Beales and Calam 1998) , and the inhibited acid secretion causes considerable change in H. pylori infection and its distribution on the corpus (Kuipers et al. 1996) . It is well known that H. pylori infection increases the risk of gastric atrophy development and carcinogenesis.
The expression level of TNF-alpha is proven to be greatly influenced by polymorphisms in its promoter region (Raabe et al. 1998) . Hence, polymorphisms in the TNFA gene promoter have been intensively studied as a putative determinant factor of susceptibility toward various diseases, including rheumatoid arthritis, psoriasis, and GC. There are many single nucleotide polymorphisms (SNPs) within the TNFA gene, such as TNFA-308 (G [ A), TNFA-238 (G [ A), TNFA-857 (C [ T), and so on. Among them, the A allele of TNFA-308 polymorphism located in the promoter is associated with increased TNF-alpha production (Kroeger et al. 1997) . Similarly, the T allele of TNFA-857 polymorphism located in the 5
0 -flanking region also shows higher transcriptional activity (Higuchi et al. 1998 ). Consequently, they are widely researched as potential susceptibility factors for GC.
In fact, there are numerous studies that focus on genetic polymorphisms and GC susceptibility or progression. However, the association between GC risk and polymorphisms found in TNFA is still controversial. El-Omar et al. found that proinflammatory genotypes of TNF-alpha were associated with more than doubling of the risk of noncardia GC (NCGC) in the USA (El-Omar et al. 2003) . Similar conclusions were obtained by Machado in Portuguese and Hou in Polish populations (Hou et al. 2007; Machado et al. 2003) . However, many other researchers' results suggest that polymorphisms of TNFA may not be significantly associated with GC risk. These studies are based on limited sample size, and participant characteristics (such as tumor localization, ethnicity, age, gender, smoking status, and so on) are different from each other. Therefore, every single study may be underpowered to achieve a comprehensive and reliable conclusion.
To better address the association between TNFA-308 and TNFA-857 polymorphisms and GC risk, we performed a meta-analysis from all eligible studies, including subgroup analyses based on ethnicity and tumor localization.
Materials and methods

Study selection
All eligible studies were identified by searching the PubMed database for related reports published before November 2007 using the following search criterion: (''gastric'' or ''stomach'') and (''cancer'' or ''adenocarcinoma'' or ''carcinoma'') and (''polymorphism'' or ''polymorphisms'') and (''tumor necrosis factor-alpha'' or ''TNF-alpha'' or ''TNFA'' or ''TNF-A''). References of retrieved articles were also screened. Articles reporting the association between GC and TNFA-308 or TNFA-857 polymorphisms were identified. Included studies must meet all the following criteria: (a) based on unrelated individuals, pedigree data were excluded, (b) genotype distributions in both cases and controls were available, and (c) the genotype distribution of the control population must be in Hardy-Weinberg equilibrium (HWE).
Data extraction
Two investigators collected the data independently and reached a consensus on all items. The following basic information was extracted from the eligible studies: first author, year of publication, ethnicity of study population, sample size, type of sample for genotyping, tumor localization, gender, age, and other variables that can be sources of bias. Genotype distribution in both cases and controls were also obtained.
Statistical analysis
Meta-analysis
Odd ratios (OR) corresponding to a 95% confidence interval (CI) were used to assess the strength of association between TNFA polymorphisms and GC. Unadjusted OR of each study was first calculated in a 2 9 2 table. The metaanalysis examined the association between TNFA-308 allele A and GC risk compared with that for allele G (A vs. G); homozygote AA was contrasted with GG. Recessive (AA vs. GA + GG) and dominant (AA + GA vs. GG) models for allele A were also used. The same contrasts were performed for allele T of the TNFA-857 polymorphism. Between-study heterogeneity was assessed by a chisquare-based Q statistic test according to Lau (Lau et al. 1997) . Heterogeneity was considered significant when P \ 0.10. A random-effects (RE) model using the DerSimonian and Laird method and a fixed-effects (FE) model using the Mantel-Haenszel method were usually used to pool the results. Two methods produced similar results in the absence of heterogeneity. The RE model was more appropriate when a significant heterogeneity was present. Both the FE and RE models were used in Review-Manager 4.2 software, and pooled OR under both models were presented for a clearer comparison. The significance of pooled OR was tested by Z test (P \ 0.05 was considered significant).
Population stratification
For TNFA-308 contrasts, subgroup analyses according to ethnicity (Caucasians, east Asians, and others) and tumor location (NCGC) were performed to estimate OR in specific populations. The TNFA-857 comparisons were not stratified for subgroup analysis because of the limited number of studies.
Sensitivity analysis
Through sequential omission of individual studies under various contrasts in Caucasian, east Asian and NCGC subgroups, respectively, sensitivity analysis was performed.
Assessment of publication bias
Funnel plots were used to investigate publication bias, where standard error of log (OR) of each study was plotted against its OR. Funnel plot asymmetry was assessed by the method of Egger's linear regression test, a linear regression approach to measure funnel plot asymmetry on the natural logarithm scale of the OR (Egger et al. 1997) . The significance of the intercept was determined by the t test, as suggested by Egger, and a P value of\0.05 was considered significant.
Software used
Hardy-Weinberg equilibrium was tested by the chi-square test using a Web-based program (http://www.ihg.gsf.de/ cgi-bin/hw/hwa1.pl); Review-Manager 4.2 and stata 8.0 were also used in our meta-analysis. All P values were two-sided.
Results
Included studies
With our search criterion, 49 papers were found. Twentyfive papers concerning research on association between TNF-alpha and GC risk were identified, 21 of them meeting our criteria. Two papers (Fei et al. 2004; Seno et al. 2007 ) did not provide detailed genotype information. One paper (Wu et al. 2003) was excluded, as it was replaced by its later report (Wu et al. 2004) . Three comparisons about TNFA-308 (Guo et al. 2005; Wu et al. 2004 Wu et al. , 2002 and one comparison about TNFA-857 (Zambon et al. 2005) were excluded because the genotype distribution for the control population therein did not accord with HWE. Eighteen eligible articles (El-Omar et al. 2003; Garcia-Gonzalez et al. 2007 Glas et al. 2004; Hou et al. 2007; Jang et al. 2001; Kamangar et al. 2006; Kim et al. 2006; Lee et al. 2005 Lee et al. , 2004 Li et al. 2005; Lu et al. 2005; Machado et al. 2003; Morgan et al. 2006; Perri et al. 2005; Rocha et al. 2005; Sugimoto et al. 2007; Zambon et al. 2005) referred to TNFA-308 polymorphism of TNFA; one of them had researched two geographic areas with different prevalence rates of GC, thus being treated as two independent studies (Perri et al. 2005) . Five eligible articles Ohyama et al. 2004; Shirai et al. 2006; Sugimoto et al. 2007; Wu et al. 2004) were about TNFA-857 polymorphism.
Finally, 19 and five studies were considered for metaanalysis concerning TNFA-308 and TNFA-857, respectively. Populations were categorized into Caucasian, east Asian, mixed, and others. Data on NCGC patients were separated as a subgroup.
Meta-analysis database
Characteristics of the included studies are shown in Table 1 . Among the 21 included articles, seven (33%) stated that controls were age-matched. All articles used blood samples for genotyping assay. Paraffin-embedded cancer tissue sections (two articles) and frozen biopsy specimens (three articles) were also used in some articles at the same time. A total of 3,335 GC patients and 5,286 controls (TNFA-308) and 1,118 GC patients and 1,591 controls (TNFA-857) were investigated. Genotype and allele distributions of TNFA -308 are shown in Table 2 , including NCGC patient-based data. Nineteen comparisons (eight in Caucasians, seven in east Asians, two in the other population, two populations with mixed ethnic background) were considered for TNFA-308 and five comparisons (all in east Asians) for TNFA-857. The genotype GG was more common in east Asians (87.82% in patients and 88.44% in controls) than in Caucasians (70.86% in patients and 76.15% in controls), whereas GA (11.58% in patients and 11.14% in controls) and AA (0.60% in patients and 0.42% in controls) genotypes of this site were in a lower incidence in east Asians. Genotype and allele distributions of TNFA -857 are shown in Table 2 .
Effects of allele and subgroup analysis
Pooled OR and other results are shown in Table 3 . For TNFA -308 comparison, there was a significant betweenstudy heterogeneity among 19 studies with respect to association between the A allele and GC susceptibility compared with the G allele (P heterogeneity = 0.05). Under the RE model, the pooled OR suggested that TNFA-308 allele A was associated with an increased risk of GC when compared with the G allele in worldwide populations (P = 0.02, RE OR 1.19; 95% CI 1.03-1.37, Fig. 1a ). No significant heterogeneity existed in the subgroup analysis of Caucasian populations (P heterogeneity = 0.15). Under the FE model, a significant result was produced (A vs. G, FE OR 1.27; 95% CI 1.11-1.45, P = 0.0005). On the other hand, significant heterogeneity was observed in the subgroup analysis of east Asians (P heterogeneity = 0.04), and no significant association between the A allele and GC risk was detected (A vs. G, RE OR 1.06; 95% CI 0.72-1.56, (Table 3 ). In the NCGC patient-based subgroup study, no obvious associations were found between A allele or AA genotype and disease risk in all contrasts (Table 3) . A total of five studies were included in association investigation of TNFA-857 polymorphism and GC risk. No significant between-study heterogeneity was found in any comparison. There was a weak but significant association between the T allele and GC risk compared with the C allele (P heterogeneity = 0.38, FE OR 1.17; 95% CI 1.01-1.35, P = 0.04, Fig. 2 ). But other contrasts produced no significant results. Since all studies were in the east Asian population, no further segmentation could be made. Other relating characters of the meta-analysis are shown in Table 3 .
Sensitivity analysis
With regard to TNFA-308 polymorphism, the results pattern was not impacted by any single study in all subgroup studies (data not shown). Similar sensitivity analysis was also performed in comparisons of TNFA-857, the pooled OR (including 95% CI) consistently encompassed 1.0 in all contrasts when each single study referring to TNFA-857 polymorphism was excluded.
Publication bias
Funnel plot from comparisons of A versus G of TNFA-308 and T versus C of TNFA-857 polymorphism in the OR analysis was performed to assess publication bias. An Egger's test was performed to statistically evaluate funnel plot symmetry, which provided no significant evidence for publication bias (t = -0.158, P = 0.132 for TNFA-308; t = 1.64, P = 0.20 for TNFA-857).
Discussion
This article investigated the relationship between TNFA polymorphisms and GC susceptibility. The overall results of this meta-analysis suggest that the A allele of the TNFA-308 Glas (2004) Caucasian (Germany) 66 (75) 19 ( locus causes an increased susceptibility to GC in worldwide and Caucasian populations. Comparisons under the recessive model and homozygote contrast supported the conclusion of allelic analysis. Sensitivity analysis showed that none of the results were affected by omission of any single study, indicating stability and reliability of the results. The association between TNFA-308 polymorphism and GC risk accorded with other functional research on TNFA, suggesting that the A allele of TNFA-308 site could apparently increase the transcription activity of this gene, and excessive expression of TNFA is related to inflammation or cancer promotion, as mentioned above. As shown in Table 3 , no significant results were produced under the dominant model, implying that a dose effect may exist for this polymorphism. However, such association was revealed to be insignificant in east Asian subgroup studies. Many factors may contribute to such discrepancy between Caucasian and east Asian populations. First, allele and genotype distribution of TNFA-308 locus was different in these two ethnicities. Percentage of A allele was especially low in east Asian populations, with 6.39% for cases and 5.99% for controls. Percentage of AA genotype was also lower in east Asian populations. Such statistical decrease might have led to the loss of association between TNFA-308 polymorphism and GC risk. Meanwhile, CIs for effect sizes in both Caucasian and east Asian populations overlapped with each other and suggest that there may be no differences between the two groups but simply a lack of power to detect an effect in east Asian studies. Moreover, different populations usually have different linkage disequilibrium (LD) patterns. For instance, a polymorphism locus may be in close linkage with another causal variant of disease risk. Such variant may exist only in a certain population and thus such association between the polymorphism and the disease risk may be lost in another population. Last but not least, clinical heterogeneity such as age, gender ratio, dietary, and disease severity of each population may also have an effect. Notably, the study by Garza-Gonzalez et al. ( 2005) in Mexico showed tremendously different genotype frequencies when compared with all other studies. And other analyses of TNFA-308 allele frequencies and genotype distribution in Mexican populations seem to be similar to those observed in other populations. Therefore, the reason for such difference in this study was unclear, and further research was needed. No significant association between TNFA-308 polymorphism and NCGC was found. Discrepancy in GC and NCGC was also observed when researchers explored the association between H. pylori infection and GC risk (Huang et al. 1998 ). This may be attributed to different pathogenic mechanisms between NCGC and other kinds of GC. However, analysis with larger populations and contrasting analysis about both cardia GC and NCGC were desired to further explain the different effects of the A308 variant on them.
Our study also indicated that the T allele of TNFA-857 polymorphism may be associated with higher risk of GC in T vs. C comparison. The association was also supported by reports about increased transcriptional activity of the T allele and the pathological role of excessive expression of TNF-alpha. But analysis under dominant recessive models and homozygote contrast indicated insignificant association between TNFA-857 polymorphism and GC risk. Furthermore, results were easily affected by single study in sensitivity analysis, which indicated a limited number of studies and sample size, and current available studies were limited in east Asian populations. After reviewing additional studies on the association between TNFA-857 polymorphism and other diseases, we found that the percentage of T-allele carrier was slightly lower in Caucasian populations (data not shown). Theoretically, this would reduce the incidence of GC provided that the T allele was related to an increased risk of this disease. But explicit indication could not be made merely according to the genotype distribution of existing healthy controls. Other factors such as diet, genetic background, public sanitation, and so on must be considered at the same time. Hence, specific research on this polymorphism and GC risk was deemed necessary in Caucasian populations. Considering the fact that GC is a complex disease, many genetic variants may affect its pathogenesis and progression. Hence, haplotype analysis is recommended to explore the combined effects of polymorphisms.
H. pylori infection was also a modifier factor of GC. H. pylori strain and host genotypes possibly influenced the host inflammatory response and epithelial-cell physiology, thus changing the risk of carcinogenesis (Peek and Blaser 2002) . Zambon et al. (2005) reported that H. pylori infection was associated with TNFA-308 genotype. Also, a meta-analysis suggested that H. pylori infection was strongly associated with early GC (Huang et al. 1998 ). Kim et al. (2006) provided separate genotyping data on H. pylori infection status-matched patients and healthy controls, which suggested that genetic polymorphisms could have considerable effect in H. pylori-induced gastroduodenal diseases. However, studies with detailed H. pylori infection status information were so limited that they were not sufficient to support analysis clarifying the modifying effect of H. pylori infection. Fig. 2 Overall meta-analysis for tumor necrosis factor-alpha (TNFA)-857 polymorphism (T vs. C allele) in gastric cancer. The study is shown by a point estimate of the odds ratio (OR) and the accompanying 95% confidence interval (CI) under a fixed-effects model. n indicates the total number of T alleles; N indicates the total number of C plus T alleles In conclusion, results of this meta-analysis indicate that the A allele of TNFA-308 polymorphism is related to increased incidence of GC, especially in Caucasian populations. TNFA-857 polymorphism T variant may be also correlated to higher GC risk. Further detailed investigation with larger numbers of worldwide participants is needed. And other confounding risk factors, such as age, gender, life style, and especially H. pylori infection status should also be taken into account when elucidating the clinically important risk factors for GC.
